Research grants can lead to incredible discoveries

February 2009
Clinical Trials Administrator;Feb2009, Vol. 7 Issue 2, p15
The article emphasizes the need to provide research grants which could potentially lead to new discoveries in the field of medicine. According to William Lawson, an assistant professor at Vanderbilt University in Nashville, Tennessee, one area that needs more research funding is in finding antibiotics that work against drug-resistant organisms. He notes that the National Institutes of Health (NIH) has been under-funded since 2003. With tighter grant funding, scientists are now less willing to take chances on breakthrough research.


Related Articles

  • NIH biomedical foundation finds its feet. D.G. // Nature;9/12/1996, Vol. 383 Issue 6596, p198 

    Announces the start of the National Foundation for Biomedical Research in Maryland; Its authorization from Congress in 1990 and 1993; Its status as a tax-exempt foundation; The focus of its efforts and resources; The mission of the National Institutes for Health; The foundation's executive...

  • (HEALTH RESEARCH) NIH Devotes $80M to Innovative Early Investigators.  // Community Health Funding Week;9/11/2009, p8 

    The article presents information on the U.S. National Institutes of Health's (NIH's) 2010 NIH Director's New Innovator Award Program. The award program supports a small number of early stage investigators who propose innovative new research approaches that have the potential to produce a major...

  • One from the many: Honing multicenter clinical trials.  // Clinical Trials Administrator;Feb2009, Vol. 7 Issue 2, p19 

    The article reveals the importance of a departmental research infrastructure to make clinical trial (CT) research more efficient and feasible when multicenter clinical trials are involved. An example is the obstetrics and gynecology research network (OGRN) which has a multicenter clinical trial...

  • Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Lamarre-Cliche, Maxime; Castilloux, Anne-Marie; LeLorier, Jacques // Clinical & Investigative Medicine;Apr2001, Vol. 24 Issue 2, p83 

    Conclusions: Disease-specific MRCC grants in the past 5 years correlated with 2 of the usual burden-of-disease parameters: disability-adjusted life-years and disease prevalence. A statistically-significant correlation was observed between disease-specific grants awarded by the MRCC and the NIH.

  • The electronic Scientific Portfolio Assistant: Integrating scientific knowledge databases to support program impact assessment. Haak, Laurel L.; Ferriss, Will; Wright, Kevin; Pollard, Michael E.; Barden, Kirk; Probus, Matt A.; Tartakovsky, Michael; Hackett, Charles J. // Science & Public Policy (SPP);Aug2012, Vol. 39 Issue 4, p464 

    The US National Institutes of Health (NIH) supports basic and applied biomedical research by funding grants and contracts. To measure the outcomes and impact of their programs, NIH staff conduct program evaluations and undertake targeted investigations of research portfolios. Recently, the NIH...

  • In tough market, local researchers score big grants. Fikes, Bradley J. // San Diego Business Journal;7/17/95, Vol. 16 Issue 29, p1 

    Reports on the National Institutes of Health's (NIH) awarding of separate federal grants to two researchers in San Diego, California, to study street-related chemicals and juvenile diabetes. Wylie Vale, faculty member and senior investigator at the Salk Institute for Biological Studies; Nora...

  • Reduced grants set off short fuses among US scientists. Ready, Tinker // Nature Medicine;Jun2005, Vol. 11 Issue 6, p582 

    The article reports that infectious disease researchers in the U.S. are irate over a decision by the U.S. National Institutes of Health to shorten the length of some existing grants by three to six months. The primary reason for the change is to stagger the U.S. National Institutes of Allergy...

  • Betting big on an AIDS vaccine.  // Nature Medicine;Jun2005, Vol. 11 Issue 6, p579 

    The article reports that the U.S. National Institutes of Health (NIH) is launching a major new initiative intended to speed progress toward an effective AIDS vaccine, which could funnel more than $300 million into the field over the next seven years. The strategy is a gamble and the NIH should...

  • Learning to share.  // Nature Medicine;Jul2012, Vol. 18 Issue 7, p989 

    The author reflects on the budgetary cuts in the biomedical research in the U.S. and abroad. According to the new budget of the U.S. National Institutes of Health (NIH), it is going to increase the number of new competing research project grants (RPGs). their are various strategies to maintain...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics